EXTERNAL PATCH CONTAINING ESTROGEN AND/OR PROGESTOGEN
    1.
    发明公开
    EXTERNAL PATCH CONTAINING ESTROGEN AND/OR PROGESTOGEN 有权
    外部PFLASTER MITÖSTROGENUND / ODER GESTAGEN

    公开(公告)号:EP1623711A1

    公开(公告)日:2006-02-08

    申请号:EP04732726.7

    申请日:2004-05-13

    摘要: An external patch capable of stable prolonged release and transdemtal absorption of active ingredient hormones (estrogens and/or progestogens) contained in a pressure sensitive adhesive layer, which external patch ensures low irritation on the skin. In particular, an external patch comprising a support and, superimposed thereon, a pressure sensitive adhesive layer, characterized in that the pressure sensitive adhesive layer comprises, as indispensable components, 5 to 50 wt.% of styrene/isoprene/styrene block copolymer, 20 to 70 wt.% of tackifier resin, 10 to 60 wt.% of softener and 1 to 20 wt.% of polyvinylpyrrolidone and contains, as an active ingredient, estrogen and/or progestogen.

    摘要翻译: 包含在压敏粘合剂层中的活性成分激素(雌激素和/或孕激素)的稳定的延长释放和透过吸收的外部贴剂,该外部贴片确保对皮肤的低刺激性。 特别地,包括支撑体并且叠加在其上的压敏粘合剂层的外部贴片,其特征在于,所述压敏粘合剂层包含5至50重量%的苯乙烯/异戊二烯/苯乙烯嵌段共聚物,20重量% 至70重量%的增粘树脂,10至60重量%的软化剂和1至20重量%的聚乙烯吡咯烷酮,并且含有作为活性成分的雌激素和/或孕激素。

    FEMALE HORMONE-CONTAINING PATCH
    4.
    发明公开
    FEMALE HORMONE-CONTAINING PATCH 有权
    雌二醇引发Pflaster

    公开(公告)号:EP1547600A1

    公开(公告)日:2005-06-29

    申请号:EP03784555.9

    申请日:2003-08-07

    摘要: Provided herein is a female hormone-containing patch wherein an active ingredient is highly soluble in a pressure-sensitive adhesive layer and the active ingredient is not adsorbed to a backing, and the patch per se can follow the irregularities on the skin surface or body movements. The patch is an external patch containing, as a female hormone, a follicular hormone estradiol and/or its derivative or a progestational hormone norethisterone and/or its derivative. The external patch comprises an acrylic pressure-sensitive adhesive containing 0.01 to 1% by weight of an isocyanate-based crosslinking agent as an essential ingredient.

    摘要翻译: 本文提供了一种含雌激素的贴剂,其中活性成分高度可溶于压敏粘合剂层,并且活性成分不吸附到背衬上,并且贴剂本身可以遵循皮肤表面上的不规则或身体运动 。 补片是含有雌激素,卵泡激素雌二醇和/或其衍生物或孕激素炔诺酮和/或其衍生物的外部补片。 外部贴片包含含有0.01〜1重量%的异氰酸酯系交联剂作为必要成分的丙烯酸类压敏粘合剂。

    PATCH CONTAINING 4-BIPHENYLACETIC ACID
    5.
    发明授权
    PATCH CONTAINING 4-BIPHENYLACETIC ACID 有权
    铺路4-联

    公开(公告)号:EP1300143B1

    公开(公告)日:2007-04-11

    申请号:EP01934446.4

    申请日:2001-05-31

    IPC分类号: A61K31/192 A61K9/70

    CPC分类号: A61K9/7053 A61K31/192

    摘要: An anti-inflammatory analgesic patch which contains 4-biphenylacetic acid, which is a sparingly soluble anti-inflammatory analgesic, and two or more drug resolvents and which is hence improved in the releasability of 4-biphenylacetic acid from the base and in the sustained release thereof and is reduced in skin irritation. The patch contains as essential ingredients 5 to 50 wt.% styrene/isoprene/styrene block copolymer, 0.05 to 20 wt.% N-methyl-2-pyrrolidone, 0.1 to 20 wt.% polyethylene glycol, and 0.1 to 20 wt.% 4-biphenylacetic acid.

    PATCH PREPARATIONS FOR PERCUTANEOUS ABSORPTION
    6.
    发明公开
    PATCH PREPARATIONS FOR PERCUTANEOUS ABSORPTION 失效
    贴片制备的经皮吸收

    公开(公告)号:EP0968710A1

    公开(公告)日:2000-01-05

    申请号:EP98919538.3

    申请日:1998-05-11

    IPC分类号: A61K9/70

    摘要: Patch preparations for percutaneous absorption with the use of supports showing an appropriate strength as a patch support, which are excellent in drug barrier characteristics, compatibility with the skin, ODT effects and handling characteristics and can sustain these specific properties in a stable state over a prolonged period of time, thus ensuring good percutaneous absorption of drugs. In these patch preparation, use is made as the support of polyester film/nonwoven vinylon fabric laminates showing an elongation percentage of at least 5 % and a tensile cutting load of at least 0.5 kg/10 mm, when measured by the test method specified in JIS K6732. In particular, the thickness of the polyester film constituting the laminate supports ranges from 1.5 to 6.0 µm and the unit weight of the nonwoven vinylon fabric ranges from 3 to 12 g/m 2 .

    摘要翻译: 使用具有适当强度的支持物作为贴剂支持物的经皮吸收贴剂制剂,其具有优异的药物屏障特性,与皮肤的相容性,ODT效应和处理特性,并且可以长时间保持稳定状态下的这些特定性质 一段时间,从而保证药物良好的经皮吸收。 在这些贴剂制备中,使用如下测量方法作为支持聚酯薄膜/非织造维尼纶织物层压材料,该层压材料显示出至少5%的伸长率和至少0.5kg / 10mm的拉伸切割负荷, JIS K6732。 特别地,构成层压支撑体的聚酯膜的厚度为1.5〜6.0μm,无纺维尼纶织物的单位重量为3〜12g / m 2。

    PLASTERS CONTAINING ISOSORBIDE NITRATE
    7.
    发明授权
    PLASTERS CONTAINING ISOSORBIDE NITRATE 失效
    硝酸异山梨CONTAIN TENDE石膏

    公开(公告)号:EP0968713B1

    公开(公告)日:2008-07-30

    申请号:EP98919537.5

    申请日:1998-05-11

    IPC分类号: A61K31/34 A61K9/70 A61K47/32

    摘要: Patches containing isosorbide nitrate, having sufficient tackiness in the application thereof, and stabilized in the release of the drug after the application. The patches are characterized in that isosorbide nitrate is added as the active ingredient to tacky plasters containing as the essential ingredients styrene-isoprene-styrene block copolymers, rosin resins, liquid rubbers, antioxidants and oleic acid. More particularly, 15 to 25 % (w/w) of isosorbide nitrate is added to plasters containing 15 to 35 % of styrene-isoprene-styrene block copolymers, 35 to 55 % of rosin resins, 5 to 20 % of liquid rubbers, 0.1 to 2 % of antioxidants and 0.1 to 5 % of oleic acid.

    PATCH CONTAINING 4-BIPHENYLACETIC ACID
    9.
    发明公开
    PATCH CONTAINING 4-BIPHENYLACETIC ACID 有权
    铺路4-联

    公开(公告)号:EP1300143A1

    公开(公告)日:2003-04-09

    申请号:EP01934446.4

    申请日:2001-05-31

    IPC分类号: A61K31/192

    CPC分类号: A61K9/7053 A61K31/192

    摘要: It is provided the plaster of anti-inflammatory and analgesic, improving the sustained releasing of 4-biphenylacetic acid from the base adhesive material and low skin irritation, by using more than two kinds of resolvent for 4-biphenylacetic acid having low solubility in solvents. More specifically, it is provided plasters essentially containing 5-50% by weight of styrene-isoprene-styrene block copolymer, 0.05-20% by weight of N-methyl-2-pyrrolidone, 0.1-20% by weight of polyethylene glycol and 0.1-20% by weight of 4-biphenylacetic acid.